GAMMA Investing’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$638K Sell
9,971
-4,758
-32% -$313K 0.02% 545
2026
Q1
$1.05M Buy
14,729
+1,398
+10% +$110K 0.05% 333
2025
Q4
$1.09M Buy
13,331
+2,230
+20% +$174K 0.05% 294
2025
Q3
$834K Buy
11,101
+2,031
+22% +$151K 0.05% 344
2025
Q2
$672K Sell
9,070
-489
-5% -$34K 0.04% 383
2025
Q1
$772K Buy
9,559
+1,543
+19% +$133K 0.06% 298
2024
Q4
$627K Buy
8,016
+355
+5% +$30.2K 0.05% 305
2024
Q3
$719K Buy
7,661
+1,784
+30% +$150K 0.07% 253
2024
Q2
$458K Buy
5,877
+1,099
+23% +$89.6K 0.06% 276
2024
Q1
$434K Buy
4,778
+736
+18% +$61.2K 0.09% 213
2023
Q4
$297K Buy
+4,042
New +$283K 0.08% 230

Other funds holding GEHC

GAMMA Investing's GEHC Position: Q2 2026 in Review

GAMMA Investing reduced its GE HealthCare (GEHC) stake by 32% in Q2 2026, selling an estimated $313K and leaving 9,971 shares worth $638K. The position accounts for 0.02% of the portfolio, ranked #545.

GAMMA Investing first reported a position in GEHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.09M in Q4 2025. 276 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • GAMMA Investing held 9,971 shares of GE HealthCare worth $638K as of Q2 2026.
  • GAMMA Investing sold 4,758 GE HealthCare shares in Q2 2026, an estimated $313K.
  • GE HealthCare made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #545 holding.
  • GAMMA Investing first reported a position in GE HealthCare in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's GE HealthCare position peaked at $1.09M in Q4 2025.
  • 276 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.